Sanofi: Information concerning the total number of voting rights and shares – December 2023
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Pharmaceuticals, Biotechnology and Life Sciences
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
SOUTH SAN FRANCISCO, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on…
FOSTER CITY, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing…
First patient dosed in company’s second clinical program with initial data expected in second half of 2024Cash runway extended into…
Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the…
STARTICLES, referring to proprietary and novel solid-state particulates suspended within a drug-in-adhesive patch for delivery of active pharmaceutical ingredients (API)…
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4)NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE)…
– Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose…
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 15, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical…